Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Alector, Inc.

NASDAQ: ALEC · Life Sciences · 5 alerts · CIK 1653087

Share price
$2.57Close, Nov 16
Market cap
$383M
Shares outstanding
148.88MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Alector, Inc. filings on SEC EDGAR ↗

4:47 PM ET 8-K
Capital Raise

Alector Capital Raise of $75M

Alector, Inc. entered into an underwriting agreement to sell 36,600,000 shares of common stock in a public offering at $2.05 per share. The company expects to receive gross proceeds of approximately $75 million to fund research, development, and general corporate purposes. The offering includes participation from institutional investors including TCGX and BVF Partners.

Value
$75M
Counterparty
Morgan Stanley & Co. LLC
7:00 AM ET 8-K
Licensing Deal

Alector Licensing Deal with Genentech, Inc. Worth $100M

Alector entered into an exclusive global licensing agreement with Genentech to develop and commercialize AL050, a brain-penetrant engineered GCase enzyme replacement therapy for Parkinson’s disease. Alector will receive a $100 million upfront payment and is eligible for up to $1.17 billion in additional milestone payments plus tiered royalties on net sales. The deal extends Alector's cash runway into 2029 while allowing the company to retain ownership of its proprietary Alector Brain Carrier platform.

Value
$100M
Counterparty
Genentech, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.